Digitalisation & Artificial Intelligence
20/21 April 2027, Wiesbaden/Germany
Highlights
- Annex 22 ‚Artificial Intelligence‘ update
- Practical use of AI: Case studies from pharmaceutical companies
- The use of AI and the compliance challenge
Objectives
In this conference session, we will provide an overview of the current state of digitalisation and the use of artificial intelligence in the pharmaceutical industry. You will learn how digitalisation can be implemented to increase efficiency and improve quality. Practical projects will be presented using various case studies from pharmaceutical companies.
Background
New forms and approaches to digitalisation are increasingly finding their way into the pharmaceutical industry. While automation is already well advanced, topics such as AI, IoT and Industry 4.0 are already in the starting blocks. Artificial intelligence has entered the mainstream since Chat GPT and Bard, but it has also found its way into the pharmaceutical industry.
Therefore, the track will also deal with artificial intelligence and present and discuss initial experiences from established projects. The focus is on GxP-relevant aspects from the perspective of the pharmaceutical industry and regulatory authorities.
Target Audience
The event is aimed at professionals from the pharmaceutical industry as well as engineers and planners involved in digitalisation and AI projects.
It is particularly aimed at the following departments:
- IT
- Production
- Quality assurance
- Engineering / Technology
